Clinical Trial Update: OPTION-EMEA Clinical Trial [NA]

View source ↗

Summary

The OPTION-EMEA clinical trial by Boston Scientific evaluating left atrial appendage closure and pulsed field ablation for atrial fibrillation is not yet recrui…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atrial Fibrillation

Snippet

Sponsor: Boston Scientific Corporation | Conditions: Atrial Fibrillation (AF), Stroke Prevention in Patients With Atrial Fibrillation | NA | Status: NOT_YET_RECRUITING